Genexine
GE
About
Genexine is a biopharmaceutical company dedicated to developing innovative biologics to address serious health issues and improve patient lives. They focus on creating novel immunotherapies for cancer and antibody therapies for rare diseases, utilizing proprietary platforms like the long-acting hyFc® Fusion Platform and DNA Vaccine Platform. Their pipeline includes treatments for anemia, growth hormone deficiency, and cervical cancer, aiming to save lives through scientific innovation.
Key facts
At-a-glance profile data
- Website
- genexine.com
- Headquarters
- Seoul, South Korea
- Founded
- 1999
- Total funding
- $297M (Funding)
- Business model
- B2B
Funding rounds
Tech stack
Detected on genexine.com, last scanned 6 Sept 2026. Run your own scan
- Email provider
- Self-hosted
Add first review
Frequently asked
How much funding has Genexine raised?
Genexine has raised a total of $297M in funding. The most recent round on record is Funding.